TPG-backed drugmaker Aptalis files for IPO of up to $500 mln

Dec 26 (Reuters) - Specialty drugmaker Aptalis Holdings Inc, owned by private equity firm TPG Capital LP, filed with U.S. regulators to raise up to $500 million in an initial public offering of its...

from Reuters: Financial Services and Real Estate http://feeds.reuters.com/~r/reuters/financialServicesRealEstateNews/~3/C9nIGKiPHuc/story01.htm